The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Reactivation of hepatitis B infection among patients with cancer.
J. Hwang
Consultant or Advisory Role - Gilead Sciences
Research Funding - Bristol-Myers Squibb
Other Remuneration - Gilead Sciences
M. Fisch
No relevant relationships to disclose
H. Zhang
No relevant relationships to disclose
M. Kallen
No relevant relationships to disclose
M. Routbort
No relevant relationships to disclose
L. S. Lal
No relevant relationships to disclose
J. Vierling
Consultant or Advisory Role - Bristol-Myers Squibb; Gilead Sciences
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; Gilead Sciences; Roche
M. Suarez-Almazor
No relevant relationships to disclose